The overexpression of LAMC1 is related to tumor progression and poor prognosis in cancers such as endometrial carcinoma (Kunitomi et al., 2020), hepatocellular carcinoma (Zhang et al., 2017), gastric cancer (Han et al., 2021) and meningioma (Ke et al., 2013), highlighting the significance of molecular targeting LAMC1 in cancer treatment. This evidence concerns the gene LAMC1 and gastric cancer.